Answers are grounded in this paper and cite their sources.
Current sampling methods to diagnose cutaneous leishmaniasis are invasive and painful. An alternative and minimally invasive microbiopsy device was evaluated in a diverse range of cutaneous leishmaniasis lesions in Ethiopia. Using polymerase chain reaction-based diagnosis, the microbiopsy outperformed the routine skin slit sample by detecting more patients while pain scores were significantly lower.
No takes yet. Share an insight, caveat, or question.
Churiso et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: